Blog
Patient acquisition, AI search, and growth for physician-led clinics.
Operator-facing posts on how clinics get found by new patients in 2026: SEO, AI search engines (ChatGPT, Perplexity, Google AI Overviews), and the physician-signed long-form content model that compounds while paid ads taper. Each piece is cited from primary FDA, FTC, peer-reviewed, and industry-data sources.
GLP-1 / Weight Loss Marketing, Q2 2026: Enforcement, Search Demand, and AI Visibility
Authoritize's Q2 2026 quarterly report on GLP-1 / Weight Loss marketing: FDA and FTC enforcement, search demand, and which providers AI assistants name.
Medical Spa / Aesthetics Marketing, Q2 2026: Enforcement, Search Demand, and AI Visibility
Authoritize's Q2 2026 quarterly report on Medical Spa / Aesthetics marketing: FDA and FTC enforcement, search demand, and which providers AI assistants name.
Peptide Marketing, Q2 2026: Enforcement, Search Demand, and AI Visibility
Authoritize's Q2 2026 quarterly report on Peptide marketing: FDA and FTC enforcement, search demand, and which providers AI assistants name.
The State of Healthcare Marketing and Compliance: Q2 2026
Authoritize's Q2 2026 quarterly report: national brands are winning healthcare search and AI answers, and where local clinics can still win, compliantly.
TRT Marketing, Q2 2026: Enforcement, Search Demand, and AI Visibility
Authoritize's Q2 2026 quarterly report on TRT marketing: FDA and FTC enforcement, search demand, and which providers AI assistants name.
Peptide Marketing in 2026: Enforcement, Search Demand, and AI Visibility
FDA/FTC enforcement, search demand, and AI-search visibility for Peptide clinics. Peptide marketing enforcement reached 5 actions in the past 12 months, up +400% from 1.
Publishing Is the Easy Part: Why Medical Content Is a Living Document, Not a One-Time Purchase
Clinic content is sold as a one-time purchase, but it drifts four ways after you publish: regulation, consistency, search, and AI citations. The case for maintained authority.
The 2025 FDA Enforcement Surge: What 200+ Warning Letters Mean for Telehealth and Clinic Marketing
The FDA issued 200+ enforcement letters in 2025, a 25-year high. Why telehealth and compounded-drug marketers got named, and a 5-step copy check.
Why We Built Authoritize: Owned Authority for Clinics in the Age of AI Search
Paid acquisition is rented, AI is rewriting search, and FDA and FTC scrutiny is rising. The case for owned, cited, physician-authored authority in 2026.
Is a Real Doctor Behind This? How AI-Researched Content Is Still Authored By You
The objection to AI in clinic content is not who drafted it, but who stands behind it. How your physician stays the author of record, and how attestation proves it.
'FDA-Approved Compounded' and Other Phrases That Land Pharmacies in Trouble
How marketing language for compounded drugs triggers FDA and FTC action. What 503A and 503B pharmacies and the clinics that sell their drugs should avoid.
Where Weight-Loss Clinics Cross the FDA's Line on Compounded GLP-1
How FDA and FTC enforcement hits GLP-1 and weight-loss clinics: compounded semaglutide and tirzepatide disclosure, brand-equivalence claims, and safer copy.
Botox, Fillers, and the FDA: What Gets a Med Spa a Warning Letter
What draws FDA enforcement against med spa and aesthetics marketing: unapproved Botox, dispensing violations, topical anesthetics, and outcome claims.
The Peptide Marketing Mistakes That Draw FDA Warning Letters
What triggers FDA enforcement against peptide marketing for clinics: research-peptide supplement claims, unapproved uses, and compounder CGMP failures.
Stem Cell and Exosome Clinics: The Claims the FDA Treats as Unapproved Drugs
How FDA enforces against stem cell, exosome, PRP, and amniotic marketing claims, what trips a warning letter, and safer ways to describe regenerative medicine.
Why the FDA Flags TRT Clinics: SARMs, Cure Claims, and Compounded Testosterone
What gets TRT and testosterone marketing flagged by the FDA: SARMs sold as supplements, cure claims, and compounded testosterone. The triggers and safer phrasing.
The Marketing Claims That Trigger FDA Warning Letters for Clinics (and How to Check Your Own Copy)
The marketing claims that draw FDA Warning Letters and FTC actions against health clinics, by category with real examples, plus how to check your own copy free.
The Anatomy of a Perfect Medical Clinic Website
Patients find clinics through Google and AI answers. Seven things decide whether your site shows up, converts the visit, and stays clean against FDA and FTC guidelines.
The Hidden Cost of Letting Generic AI Write Your Clinic's Content
In one study, 93% of ChatGPT's medical citations were fabricated or wrong. Generic AI, and most medical AI writers, carry risks a clinic cannot afford.
What Is GEO Citation Tracking, and Why Your Clinic Needs It
Patients now ask ChatGPT and Google AI Overviews for care, and those answers cite a handful of sources. GEO citation tracking measures whether your clinic is one of them.
GLP-1 / Weight Loss enforcement reached 82 actions in the past 12 months, up +645.5% from 11
FDA and FTC marketing-enforcement trends from the Authoritize Atlas. GLP-1 / Weight Loss enforcement reached 82 actions in the past 12 months, up +645.5% from 11.
Google Knows You Used AI. It Doesn't Care as Long as You Did It Right.
Google and AI engines can tell when content was drafted by AI. Using AI is not what gets a clinic site buried. Here is what they actually reward: expert review, verifiable citations, and a named author.
The DPC Growth Problem Isn't Demand. It's Discovery.
Direct primary care sells itself once patients can find it. Here is why owned content, not paid ads, is how a DPC practice fills memberships and keeps them full.
E-E-A-T, GEO, YMYL, AI Overviews: A Plain-English Field Guide for Clinic Owners in 2026
A plain-English guide to the four acronyms that decide whether new patients find your clinic in 2026: E-E-A-T, GEO, YMYL, and AI Overviews, and what each one asks you to actually do.
Google Can Tell a Real Doctor Didn't Write That
Anonymous, ghostwritten health blogs are losing to content signed by a named clinician. Here is what Google and AI engines actually check, and why a doctor's byline is now a ranking signal.
Why TRT Clinics Can't Buy Their Way to New Patients Anymore
Meta and Google have quietly removed the targeting that made TRT ads work. Here is why owned, physician-signed content is now the durable way a testosterone clinic wins patients.
How Healthcare Clinics Get Found by New Patients in 2026
How Google, ChatGPT, Perplexity, Claude, and Google AI Overviews decide which clinics to recommend to new patients in 2026, and what physician-led practices need to do to show up there.